Downstream Processing

  1. Purification Tools To Address Low Yield Challenges With Protein A 5/19/2025

    Discover new affinity chromatography resins for engineered modalities. Learn how they boost yield and reduce aggregation with high-specificity binding and mild elution. Ideal for purifying novel mAbs, BsAbs, and mAb fragments.

  2. Speed Up Process Development With HTS Tools For Affinity Chromatography 7/16/2024

    High Throughput Screening (HTS) chromatography tools can accelerate process development and reduce material usage. Learn about a solution that addresses challenges with their use in new modalities.

  3. Rethinking Sustainability In Bioprocessing 5/22/2025

    Discover how sustainability is transforming bioprocessing through innovative single-use technologies that help reduce environmental impact and support responsible, forward-thinking biomanufacturing.

  4. Accelerating mAb Process Development In The Growing Therapeutics Market 8/20/2024

    The market for mAbs and mAb variants is growing rapidly. Explore the latest strategies and advancements in early stage mAb up- and downstream process development.

  5. What Bioprocessing Bottlenecks Does Process Intensification Address? 8/27/2024

    Supply chains, consumables, and data are identified as three of the management challenges that intensified processes and process automation technology (PAT) are addressing at AbbVie and AstraZeneca.

  6. Three Novel Protein Therapeutic Worldviews 9/13/2024

    In this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics, we meet panelists who share their topline perspectives on developing complex, novel protein therapeutics.

  7. mRNA-Based Therapeutics Development Through Efficient mRNA Purification 6/9/2025

    Discover how a novel affinity resin simplifies and maximizes the purification of mRNA therapeutics. Learn about the scalable technique vital for commercial manufacturing.

  8. Addressing Post-Translational Modifications In Novel Protein Therapeutics 9/13/2024

    Meinhard Hasslacher, Ph.D., Head of CMC at SOTIO Biotech, addresses an audience question on conjugation efficiencies in this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics. From there, we move on to an audience-led discussion on when to initially address titer, PTMS, and product quality during development of novel protein therapeutic cell lines, with Lena Tholen, Ph.D, Director of Cell Line and Bioprocess Development at FyoniBio and Neeraj Pakala, Ph.D. SVP of Product Development and Manufacturing at Vera Therapeutics weighing in.

  9. What's Next For Bioprocess Intensification? 8/27/2024

    Experts speaking on Bioprocess Intensification In The Real World wrap up the Bioprocess Online Live event with parting shots and reflections on the current state of process intensification and what the future holds.

  10. BioTitan Retention Device Overview 5/29/2025

    Learn about a retention device that provides robust fortification for single-use assemblies. Its 360-degree seal strengthens connections, reduces leak risks, and ensures process integrity for fluid transfer.